Companies House 15874737 2025-08-31 2025-08-31 2024-08-03 false iso4217:GBP xbrli:pure 15874737 2025-08-31 15874737 2024-08-03 2025-08-31 15874737 curr:PoundSterling 2024-08-03 2025-08-31 15874737 uk-bus:PrivateLimitedCompanyLtd 2024-08-03 2025-08-31 15874737 uk-bus:FRS102 2024-08-03 2025-08-31 15874737 uk-bus:AuditExempt-NoAccountantsReport 2024-08-03 2025-08-31 15874737 uk-bus:FullAccounts 2024-08-03 2025-08-31 15874737 uk-bus:RegisteredOffice 2024-08-03 2025-08-31 15874737 uk-bus:Director1 2024-08-03 2025-08-31 15874737 uk-bus:Director2 2024-08-03 2025-08-31 15874737 uk-bus:Director3 2024-08-03 2025-08-31 15874737 uk-bus:Director4 2024-08-03 2025-08-31 15874737 uk-bus:Director5 2024-08-03 2025-08-31 15874737 uk-bus:Director6 2024-08-03 2025-08-31 15874737 uk-bus:Director7 2024-08-03 2025-08-31 15874737 uk-bus:Director8 2024-08-03 2025-08-31 15874737 uk-bus:Director9 2024-08-03 2025-08-31 15874737 uk-bus:Director10 2024-08-03 2025-08-31 15874737 uk-bus:Director11 2024-08-03 2025-08-31 15874737 uk-bus:Director12 2024-08-03 2025-08-31 15874737 uk-bus:Director13 2024-08-03 2025-08-31 15874737 uk-bus:Director14 2024-08-03 2025-08-31 15874737 uk-bus:Director15 2024-08-03 2025-08-31 15874737 uk-bus:Director16 2024-08-03 2025-08-31 15874737 uk-bus:Director17 2024-08-03 2025-08-31 15874737 uk-bus:Director18 2024-08-03 2025-08-31 15874737 uk-bus:Director19 2024-08-03 2025-08-31 15874737 uk-bus:Director20 2024-08-03 2025-08-31 15874737 uk-bus:Director21 2024-08-03 2025-08-31 15874737 uk-bus:CompanySecretary1 2024-08-03 2025-08-31 15874737 core:AfterOneYear 2025-08-31 15874737 core:WithinOneYear 2025-08-31 15874737 core:WithinOneYear 2024-08-03 2025-08-31 15874737 core:AfterOneYear 2025-08-31 15874737 core:AfterOneYear 2024-08-03 2025-08-31 15874737 core:ShareCapital 2025-08-31 15874737 core:SharePremium 2025-08-31 15874737 core:OtherReservesSubtotal 2025-08-31 15874737 core:RevaluationReserve 2025-08-31 15874737 core:RetainedEarningsAccumulatedLosses 2025-08-31 15874737 1 2024-08-03 2025-08-31 15874737 2 2024-08-03 2025-08-31 15874737 3 2024-08-03 2025-08-31 15874737 core:LandBuildings 2024-08-03 2025-08-31 15874737 core:LandBuildings 2025-08-31 15874737 core:PlantMachinery 2024-08-03 2025-08-31 15874737 core:PlantMachinery 2025-08-31 15874737 core:FurnitureFittingsToolsEquipment 2024-08-03 2025-08-31 15874737 core:FurnitureFittingsToolsEquipment 2025-08-31 15874737 core:OfficeEquipment 2024-08-03 2025-08-31 15874737 core:OfficeEquipment 2025-08-31 15874737 core:Vehicles 2024-08-03 2025-08-31 15874737 core:Vehicles 2025-08-31 15874737 core:NetGoodwill 2024-08-03 2025-08-31 15874737 core:NetGoodwill 2025-08-31 15874737 core:IntangibleAssetsOtherThanGoodwill 2024-08-03 2025-08-31 15874737 core:IntangibleAssetsOtherThanGoodwill 2025-08-31

# COLLINS MEDICAL LIMITED

## Company Registration Number:
15874737 (England and Wales)

## Unaudited statutory accounts for the year ended 31 August 2025

## Period of accounts

## Start date: 3 August 2024

## End date: 31 August 2025

# COLLINS MEDICAL LIMITED

## Contents of the Financial Statements

for the Period Ended 31 August 2025

Directors report |
Profit and loss |
Balance sheet |
Additional notes |
Balance sheet notes |

# COLLINS MEDICAL LIMITED

Directors' report period ended 31 August 2025

The directors present their report with the financial statements of the company for the period ended 31 August 2025

Principal activities of the company

Manufacture of medical and dental instruments and supplies

Directors

The director shown below has held office during the whole of the period from
3 August 2024 to 31 August 2025

Adrian John Gee-Turner

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
1 May 2026

And signed on behalf of the board by:
Name: Adrian John Gee-Turner
Status: Director

# COLLINS MEDICAL LIMITED

## Profit And Loss Account

for the Period Ended 31 August 2025

| 13 months to 31 August 2025
--- | ---
| £
Turnover: | 33,770 |
Cost of sales: | ( 1,013 ) |
Gross profit(or loss): | 32,757
Administrative expenses: | ( 81,447 ) |
Operating profit(or loss): | (48,690)
Profit(or loss) before tax: | (48,690)
Profit(or loss) for the financial year: | (48,690)

# COLLINS MEDICAL LIMITED

## Balance sheet

As at 31 August 2025

| Notes | 13 months to 31 August 2025
--- | --- | ---
|  | £
Current assets
Debtors: | 3 | 13,864 |
Cash at bank and in hand: |  | 2,252 |
Total current assets: |  | 16,116
Creditors: amounts falling due within one year: | 4 | ( 64,707 ) |
Net current assets (liabilities): |  | (48,591)
Total assets less current liabilities: |  | (48,591)
Total net assets (liabilities): |  | (48,591)
Capital and reserves
Called up share capital: |  | 100 |
Profit and loss account: |  | (48,691 ) |
Total Shareholders' funds: |  | ( 48,591 )

The notes form part of these financial statements

# COLLINS MEDICAL LIMITED

## Balance sheet statements

For the year ending 31 August 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 1 May 2026
and signed on behalf of the board by:

Name: Adrian John Gee-Turner
Status: Director

The notes form part of these financial statements

# COLLINS MEDICAL LIMITED

## Notes to the Financial Statements

for the Period Ended 31 August 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

# COLLINS MEDICAL LIMITED

## Notes to the Financial Statements

for the Period Ended 31 August 2025

- ## 2. Employees

  | 13 months to 31 August 2025
  --- | ---
  Average number of employees during the period | 0 |

# COLLINS MEDICAL LIMITED

## Notes to the Financial Statements

for the Period Ended 31 August 2025

## 3. Debtors

| 13 months to 31 August 2025
--- | ---
| £
Trade debtors | 4,167 |
Other debtors | 9,697 |
Total | 13,864

# COLLINS MEDICAL LIMITED

## Notes to the Financial Statements

for the Period Ended 31 August 2025

## 4. Creditors: amounts falling due within one year note

| 13 months to 31 August 2025
--- | ---
| £
Trade creditors | 26,487 |
Other creditors | 38,220 |
Total | 64,707